Digest Network How does it work
Network
/
Society
Te
Not verified

Teva Pharmaceutical Industries Ltd

What we write about

FinanceManagementMedical Health WellnessPharmaceuticalsWant ads

37 Press releases

View all press releases
07/04/2025
Pharmaceuticals
Medical Health Wellness
Teva Announces FDA Filing Acceptance for AJOVY® (fremanezumab) in Pediatric Episodic Migraine Prevention
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
31/03/2025
Pharmaceuticals
Want ads
New Data Strengthens Teva’s Schizophrenia Portfolio, Including Phase 3 SOLARIS Trial Survey Results Demonstrating Patient and Healthcare Professional Satisfaction with TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
27/03/2025
Pharmaceuticals
Management
Teva Releases Q1 2025 Aide Memoire
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
27/03/2025
Pharmaceuticals
Management
Teva Releases Q1 2025 Aide Memoire
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
27/03/2025
Pharmaceuticals
Teva to Host Conference Call to Discuss First Quarter 2025 Financial Results at 8 a.m. ET on May 7, 2025
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
03/03/2025
Pharmaceuticals
Teva to Present at Barclays Global Healthcare Conference and Leerink Partners Global Healthcare Conferences in March
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
27/02/2025
Pharmaceuticals
Want ads
2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
21/02/2025
Pharmaceuticals
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
Press Release cover image
21/02/2025
Pharmaceuticals
Medical Health Wellness
Les besoins du patient au centre de toutes les priorités : pourquoi l’Europe doit agir pour protéger l’accès aux médicaments ?
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0
21/02/2025
Pharmaceuticals
Medical Health Wellness
Teva and Alvotech Announce SELARSDI™ (ustekinumab-aekn) Injection Now Available in the U.S.
Source
Teva Pharmaceutical Industries Ltd
Issuer
GLOBENEWSWIRE
1.00
0

Contact details

Social Media

Followers
0
Compatibility
0